Literature DB >> 9061084

Magnetic resonance imaging observations of blood-brain-barrier permeability in an animal model of brain injury.

J C Ford1, A K Wood, T J Van Winkle, H L Kundel.   

Abstract

RATIONALE AND
OBJECTIVES: Knowledge of the in vivo relaxivity of paramagnetic contrast agents is important in the accurate measurement of the permeability of the blood-brain barrier (BBB). This study was aimed at developing an animal model for the magnetic resonance (MR) imaging investigation of injuries to the BBB.
METHODS: MR imaging (1.9 T) was performed in 18 rats with acute, stable injuries to the brain caused by freezing. After injection of gadodiamide (0.05-0.20 mmol/kg), estimates were made of BBB permeability, leakage space, and relaxivity (also measured in saline).
RESULTS: The BBB was always disrupted at the injured site (permeability = 0.038 min-1 +/- 0.0006). The central area of necrosis and the periphery of edema showed substantial differences in leakage space and relaxivity. The relaxivity of gadodiamide was much greater at the injured site than in saline.
CONCLUSION: The in vivo relaxivity at a site of pathologic change in the brain may be substantially greater than that measured in aquo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9061084     DOI: 10.1016/s1076-6332(97)80010-4

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  2 in total

1.  In vivo assessment of aqueous humor dynamics upon chronic ocular hypertension and hypotensive drug treatment using gadolinium-enhanced MRI.

Authors:  Leon C Ho; Ian P Conner; Chi-Wai Do; Seong-Gi Kim; Ed X Wu; Gadi Wollstein; Joel S Schuman; Kevin C Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-24       Impact factor: 4.799

2.  Noninvasive and transient blood-brain barrier opening in the hippocampus of Alzheimer's double transgenic mice using focused ultrasound.

Authors:  James J Choi; Shougang Wang; Truman R Brown; Scott A Small; Karen E K Duff; Elisa E Konofagou
Journal:  Ultrason Imaging       Date:  2008-07       Impact factor: 1.578

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.